-
Mashup Score: 15Scientific Committees - 2 day(s) ago
Browse a complete roster of the ASH’s 18 scientific committees. The scientific committees help identify annual meeting topics and speakers, define a research and policy agenda for hematology, participate in ASH advocacy activities, and more.
Source: www.hematology.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Additional Fellowships: What’s the Value? | ASH Clinical News | American Society of Hematology - 10 month(s) ago
The traditional path to a career in hematology in the U.S. involves at least nine years of graduate-level training, starting with medical school and ending with a hematology or combined hematology-oncology fellowship that is certified by the Accreditation Council for Graduate Medical Education (ACGME), which accredits teaching hospitals, residencies, and fellowships. However, a small number of…
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Building a Pathway for Diverse Leaders in Hematology | ASH Clinical News | American Society of Hematology - 12 month(s) ago
As a Latin woman, walking into a large medical conference can be a lonely experience. But Jacqueline C. Barrientos, MD, said that feeling faded away for her at the American Society of Hematology (ASH) Annual Meeting when she entered a room full of hematologists who were current or former recipients of research awards granted through the Society’s Minority Recruitment Initiative (MRI), a program…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator - 1 year(s) ago
Key Points. ELT is a powerful iron chelator, mobilizing iron and ferritin, reducing ROS, and restoring insulin production at clinically achievable levels.ELT en
Source: American Society of HematologyCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Striving for Culturally Sensitive Care | ASH Clinical News | American Society of Hematology - 1 year(s) ago
The term “cultural competence” has been used in medicine for decades, with physicians aiming to deliver care that addresses a patient’s social, cultural, and language needs.1 But as the medical community – and society as a whole – grapples with complex issues like how to achieve equity and tackle structural racism, the conversation is turning to different terms, such as cultural sensitivity and…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Striving for Culturally Sensitive Care | ASH Clinical News | American Society of Hematology - 1 year(s) ago
The term “cultural competence” has been used in medicine for decades, with physicians aiming to deliver care that addresses a patient’s social, cultural, and language needs.1 But as the medical community – and society as a whole – grapples with complex issues like how to achieve equity and tackle structural racism, the conversation is turning to different terms, such as cultural sensitivity and…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future - 1 year(s) ago
PURPOSE: Conventional hematology/oncology fellowship training is designed to foster careers in academic practice through intensive exposure to clinical and laboratory research. Even so, a notable proportion of graduating fellows opt to pursue a clinically focused career outside the realm of academic medicine. Given the corresponding shortage of oncologists in nonurban and rural settings,…
Source: JCO Oncology PracticeCategories: Hem/Oncs, Latest HeadlinesTweet-
🚨🔥Hot off the press. Just published @JCOOP_ASCO @ASCO Very important article/project on: Training #Hematologists/#Oncologists for the Academic-Community Hybrid: Creating a #Fellowship Framework for the Future. 👇🏼 https://t.co/nlU2BYt7YZ #MedEd #OncMedEd #OncTwitter https://t.co/LyNw46yS6f
-
-
Mashup Score: 4Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1JNCCN 360 - B-Cell Lymphomas - Survey of Oncologists and Hematologists: Considerations in Third-Line Treatment of Follicular Lymphoma - 2 year(s) ago
By: Joseph Fanelli Posted: Thursday, August 11, 2022 For physicians treating patients with follicular lymphoma in the third-line setting, treatment efficacy and improved survival attributes are considered the most important factors when selecting among treatment options, according to findings presented at the European…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Greater AP Support May Mitigate Burnout Among Hematologists and Oncologists | ASH Clinical News | American Society of Hematology - 2 year(s) ago
While compensation plans for hematologists and oncologists based on clinical productivity alone are associated with high clinician burnout, increased support from advanced practitioners (APs) may be associated with reduced burnout among physicians who treat patients with hematologic and other malignancies, according to a study in Blood Advances. Lead author Alfred Ian Lee, MD, PhD, of Yale School…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
ASH needs #hematologists w/ the following expertise to join the Scientific Committee on Bone Marrow Failure: 🩸Inherited clonal hematopoiesis 🩸Telomere biology disorders 🩸Acquired severe aplastic anemia Details: https://t.co/ycnaaR7Drg Tag someone who should see this!👇 https://t.co/H2nBhCKCf0